Mon, May 26, 2025
[Archive]
.png)
Volume 4, Issue 3 (9-2018)
jhehp 2018, 4(3): 99-105 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tagoe E T, Agbadi P, Adomah-Afari A. Influential Factors in the Treatment Outcomes of Tuberculosis in Directly Observed Therapy at the La General Hospital in the
Greater Accra Region, Ghana. jhehp 2018; 4 (3) :99-105
URL: http://jhehp.zums.ac.ir/article-1-174-en.html
URL: http://jhehp.zums.ac.ir/article-1-174-en.html
1- Department of Health Policy, Planning and Management, School of Public Health, University of Ghana.
Abstract: (7712 Views)
Background: Tuberculosis is a major cause of morbidity and mortality in Africa, especially Ghana. Despite the current treatments for tuberculosis, positive treatment outcomes are not attainable due to the differences in the socio-economic and bio-psychological status of the patients. The present study aimed to assess the influential factors in the treatment outcomes of tuberculosis.
Methods: This qualitative study was conducted to determine the influential factors in the treatment outcomes of tuberculosis in terms of the patients, community, and healthcare providers. Data collection and management were performed using version 11 of the NVivo software. Sample population included 10 patients, five healthcare providers, and five community members (treatment supporters). Data analysis was carried out using framework analysis, where the emerging themes were identified and discussed in relation with literature.
Results: The results revealed that wrong/negative perceptions about TB, social stigma, and the use of alternative treatment methods could result in unsuccessful treatment outcomes.
Conclusion: The study recommends that community awareness of TB and the search and implementation of policies toward improving TB treatment outcome should be pursued.
Methods: This qualitative study was conducted to determine the influential factors in the treatment outcomes of tuberculosis in terms of the patients, community, and healthcare providers. Data collection and management were performed using version 11 of the NVivo software. Sample population included 10 patients, five healthcare providers, and five community members (treatment supporters). Data analysis was carried out using framework analysis, where the emerging themes were identified and discussed in relation with literature.
Results: The results revealed that wrong/negative perceptions about TB, social stigma, and the use of alternative treatment methods could result in unsuccessful treatment outcomes.
Conclusion: The study recommends that community awareness of TB and the search and implementation of policies toward improving TB treatment outcome should be pursued.
Type of Study: Original Article |
Subject:
Public Health
Received: 2018/06/14 | Accepted: 2018/08/13 | Published: 2018/09/21
Received: 2018/06/14 | Accepted: 2018/08/13 | Published: 2018/09/21
References
1. World Health Organization (WHO). Global Tuberculosis Report. World Health Organisation: Geneva; 2016. Available from: URL:http://apps.who.int/medicinedocs/documents/s23098en/s23098en.pdf.
2. Daniel TM. The History of Tuberculosis. Respir Med. 2006; 100 (11): 1862-70. [Crossref]
3. Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S. Effect of BCG Vaccination against Mycobacterium Tuberculosis Infection in Children: Systematic Review and Meta-Analysis. BMJ. 2014; 349: g4643. [Crossref]
4. Zumla A, George A, Sharma V, Herbert RHN, Masham B, Oxley A, et al. The WHO 2014 Global Tuberculosis Report-Further to Go. Lancet Glob Health. 2015; 3(1): e10-2. [Crossref]
5. Tipayamongkholgul M, Marin W, Sujirarat D, Pokaew P, Pungrassami P. Non-Communicable Diseases Increased Risk of Recurrent Tuberculosis in Epidemic Area of Human Immunodeficiency Virus Infection, Thailand. Trop Biomed. 2016; 33(1): 190-6.
6. Perrin P. Human and Tuberculosis Co-Evolution: An Integrative View. Tuberc. 2016; 95: S112-6. [Crossref]
7. National Tuberculosis Control Program, National Tuberculosis Control Programme Report on 2014 World Tuberculosis Day Commemoration. TB Ghana, 2014. Available from: URL: http://www.tbghana.gov.gh/sites/default/files/World%20TB%20day%20report%202017_0.pdf.
8. Ralph AP. L-Arginine in Pulmonary Tuberculosis, L-Arginine in Clinical Nutrition. Springer Int Publishing. 2017; 603-18. [Crossref]
9. Nliwasa M, MacPherson P, Mukaka M, Mdolo A, Mwapasa M, Kaswaswa K, et al. High Mortality and Prevalence of HIV and Tuberculosis in Adults with Chronic Cough in Malawi: A Cohort Study. Int J Tuberc Lung Dis. 2016; 20(2): 202-10. [Crossref]
10. Aggarwal AN, Agarwal R, Gupta D, Dhooria S, Behera D, et al. Interferon Gamma Release Assays for Diagnosis of Pleural Tuberculosis: a Systematic Review and Meta-Analysis. J Clin Microbiol. 2016; 54(2): 2451-9. [Crossref]
11. Mueller-Using S, Feldt T, Sarfo FS, Eberhardt KA. Factors Associated with Performing Tuberculosis Screening of HIV-Positive patients in Ghana: LASSO-Based Predictor Selection in a Large Public Health Data Set. BMC Public Health. 2016; 16(1): 563. [Crossref]
12. Marfo BA. Factors Contributing to the High Default Rate of the Dots System in the Yendi District. University of Ghan Digital Collections. 2001. Available from: URL: http://197.255.68.203 /handle/ 123456789/6252.
13. Sengul A, Akturk UA, Aydemir Y, Kaya N, Kocak ND, Tasolar F T. Factors Affecting Successful Treatment Outcomes in Pulmonary Tuberculosis: A Single-Center Experience in Turkey, 2005–2011. J Infect Dev Ctries. 2015; 9(8): 821-8. [Crossref]
14. Chimbindi N, Bärnighausen T, Newell ML. Patient Satisfaction with HIV and TB Treatment in a Public Programme in Rural KwaZulu-Natal: Evidence from Patient-Exit Interviews. BMC Health Serv Res. 2014; 14(1): 32. [Crossref]
15. Finlay A, Lancaster J, Holtz TH, Weyer K, Miranda A, Van Der Walt M. Patient- and Provider-Level Risk Factors Associated with Default from Tuberculosis Treatment, South Africa, 2002: A Case-Control Study. BMC Public Health. 2012; 12(1): 56. [Crossref]
16. Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F. Factors Associated with Default from Treatment among Tuberculosis Patients in Nairobi Province, Kenya : A Case Control Study. BMC Public Health. 2011; 11(1): 696. [Crossref]
17. Hamusse SD, Demissie M, Teshome D, Lindtjørn B. Fifteen-year Trend in Treatment Outcomes among Patients with Pulmonary Smear-Positive Tuberculosis and its Determinants in Arsi Zone, Central Ethiopia. Global Health Action. 2014; 7(1): 25382. [Crossref]
18. Soomro MH, Qadeer E, Mørkve O. Barriers in the Management of Tuberculosis in Rawalpindi, Pakistan: A Qualitative Study. Tanaffos. 2013; 12(4): 28-34.
19. Johnson RB, Onwuegbuzie AJ, Turner LA. Toward a Definition of Mixed Methods Research. J Mix Methods Res. 2007; 1(2): 112-33. [Crossref]
20. Etikan I, Musa SA, Alkassim RS. Comparison of Convenience Sampling and Purposive Sampling. Am J Theor Appl Statistics. 2016; 5(1): 1-4. [Crossref]
21. Dixon-Woods M. Using Framework-Based Synthesis for Conducting Reviews of Qualitative Studies. BMC Med. 2011; 9(1): 39. [Crossref]
22. Naidoo P, Peltzer K, Louw J, Matseke G, Mchunu G, Tutshana B. Predictors of Tuberculosis (TB) and Antiretroviral (ARV) Medication Non-adherence in Public Primary Care Patients in South Africa: A Cross sectional Study. BMC Public Health. 2013; 13(1): 396. [Crossref]
23. Amo-Adjei J, Kumi-Kyereme A, Amo HF, Awusabo-Asare K. The Politics of Tuberculosis and HIV Service Integration in Ghana. Soc Sci Med. 2014; 117: 42-9. [Crossref]
24. Amo-Adjei J. Political Commitment to Tuberculosis Control in Ghana. Global Public Health. 2014; 9(3): 299-311. [Crossref]
25. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial Burden for Tuberculosis Patients in Low-and Middle-Income Countries: A Systematic Review. Eur Respir J. 2014; 43(6): 1763-75. [Crossref]
26. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of Serious Side Effects from First-line Antituberculosis Drugs among Patients Treated for Active Tuberculosis. Am Respir Crit Care Med. 2003; 167(11): 1472-7. [Crossref]
27. Ananthakrishnan R, Kumar K, Ganesh M, Kumar AM, Krishnan N, Swaminathan S, et al. The Profile and Treatment Outcomes of the Older (aged 60 years and above) Tuberculosis Patients in Tamilnadu, South India. PloS One. 2013; 8(7): e67288-93. [Crossref]
28. Nezenega ZS, Tafere TE. Patient Satisfaction on Tuberculosis Treatment Service and Adherence to Treatment in Public Health Facilities of Sidama Zone, South Ethiopia. BMC Health Serv Res. 2013; 13(1): 110. [Crossref]
29. Paz-Soldán VA, Alban RE, Jones CD, Oberhelman RA. The Provision of and Need for Social Support among Adult and Pediatric Patients with Tuberculosis in Lima, Peru: a Qualitative Study. BMC Health Serv Res. 2013; 13(1): 290. [Crossref]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
© 2024 The Author(s)
